Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BeOne Medicines | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥237.40B | -67.6x | -1.58 | CN¥248.30 | 3.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 23% Upside | Upgrade to Pro+ | |
WuXi AppTec | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥229.79B | 21.1x | -1.09 | CN¥80.80 | 2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6% Upside | Upgrade to Pro+ | |
Hangzhou Tigermed Consulting | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥49.98B | 149.6x | -1.75 | CN¥58.41 | 3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 0.7% Upside | Upgrade to Pro+ | |
Pharmaron Beijing | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥46.81B | 24.7x | 0.88 | CN¥26.50 | 2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21.9% Upside | Upgrade to Pro+ | |
Shanghai Allist Pharmaceuticals Co | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥44.11B | 27.3x | 0.42 | CN¥99.14 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 0.8% Upside | Upgrade to Pro+ | |
RemeGen | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥37.05B | -16.5x | -2.46 | CN¥69.57 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -22.7% Downside | Upgrade to Pro+ | |
Sinocelltech Group | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥33.04B | 346.7x | 2.1 | CN¥80.50 | 8.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -34% Downside | Upgrade to Pro+ | |
InnoCare Pharma | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥32.46B | -79.6x | -3.59 | CN¥30.42 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Dizal Jiangsu Pharmaceutical | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥29.87B | -28.5x | -1.38 | CN¥66 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.9% Upside | Upgrade to Pro+ | |
InventisBio | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥23.13B | -54.2x | -8.16 | CN¥41.50 | 3.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -29% Downside | Upgrade to Pro+ | |
BGI Genomics | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥19.50B | -21.7x | 0.01 | CN¥50.82 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.2% Upside | Upgrade to Pro+ | |
Joinn Laboratories China | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥19.49B | 50.4x | 0.06 | CN¥26.60 | 5.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -30.2% Downside | Upgrade to Pro+ | |
Mabwell Shanghai Bioscience | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥12.43B | -10.8x | 0.99 | CN¥37.33 | 20% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 22.5% Upside | Upgrade to Pro+ | |
Bio-Thera Solutions | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥11.13B | -18.3x | 0.75 | CN¥29.03 | 8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15.5% Upside | Upgrade to Pro+ | |
Sino Biological | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥8.58B | 75.6x | -1.6 | CN¥72.12 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5.1% Upside | Upgrade to Pro+ | |
HitGen | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥7.14B | 95.1x | 11.31 | CN¥21.46 | 20% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -13% Downside | Upgrade to Pro+ | |
Shanghai Medicilon | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥6.60B | -21.8x | 0.02 | CN¥57.29 | 16.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Jiangsu Asieris Pharmaceuticals | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥6.22B | -13.1x | -1.95 | CN¥11.78 | 6.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -7% Downside | Upgrade to Pro+ | |
Shouyao Holdings Beijing | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥6.05B | -24.3x | 3.1 | CN¥45.25 | 11.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.5% Upside | Upgrade to Pro+ | |
GemPharmatech | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥5.96B | 46.8x | -1.89 | CN¥15.19 | 3.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -4.3% Downside | Upgrade to Pro+ | |
ChemPartner PharmaTech | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥5.66B | -30.7x | -0.33 | CN¥11.28 | 6.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Beijing Sun Novo Pharmaceutical Research | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥5.60B | 45.3x | -1.15 | CN¥53.60 | 4.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hangzhou BioSincerity PharmaTech | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥5.33B | -40.2x | 0.29 | CN¥49.51 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bide Pharmatech | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥5.26B | 30.5x | 1.68 | CN¥60.37 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -16.6% Downside | Upgrade to Pro+ | |
Hinova Pharmaceuticals | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥5.20B | -23.7x | -0.9 | CN¥53.90 | 2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10.3% Upside | Upgrade to Pro+ | |
PharmaResources Shanghai | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥5.04B | 183.2x | -20.82 | CN¥38.71 | 5.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
R G PharmaStudies | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥4.94B | 30.5x | -1.37 | CN¥54.32 | 4.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.7% Upside | Upgrade to Pro+ | |
Beijing Kawin Technology Shareholding Co | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥4.61B | 30.8x | 2.26 | CN¥29.40 | 6.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Shanghai Aladdin Biochemical Technology Co | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥4.51B | 36x | 2.59 | CN¥13.95 | 2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.3% Upside | Upgrade to Pro+ | |
Guangzhou Boji Medical & Biotech | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥4.20B | 230.4x | -5.01 | CN¥11.04 | 8.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Qingdao Vland Biotech | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥3.48B | 57x | -2.14 | CN¥13.77 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.4% Upside | Upgrade to Pro+ | |
Xinjiang Baihuacun | Shanghai | Healthcare | Biotechnology & Medical Research | CN¥3.02B | 72.3x | 1.34 | CN¥7.87 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Anhui Wanbang Pharmaceutical | Shenzhen | Healthcare | Biotechnology & Medical Research | CN¥3.01B | 37.1x | -0.93 | CN¥46.42 | 2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |